PT  - JOURNAL ARTICLE
AU  - Hoyle, Brian
ED  - Trautmann, Michael
TI  - DURATION-3 Trial Results
DP  - 2013 Sep 01
TA  - MD Conference Express
PG  - 15--16
VI  - 13
IP  - 11
4099  - http://mdc.sagepub.com/content/13/11/15.short
4100  - http://mdc.sagepub.com/content/13/11/15.full
AB  - Three-year data from the Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Metformin Alone or in Combination With Sulfonylurea trial [DURATION-3; NCT00641056] have confirmed previously reported 26- and 84-week results demonstrating the superiority of the exenatide regimen for glycemic and weight control, and lowered risk of hypoglycemia [Diamant M et al. Lancet 2010; Diamant M et al. Diabetes Care 2012].